Envestnet Asset Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21,066
Closed -$309K 4188
2023
Q4
$309K Buy
+21,066
New +$294K ﹤0.01% 3607
2022
Q3
Sell
-13,986
Closed -$230K 3908
2022
Q2
$230K Buy
13,986
+3,722
+36% +$63.8K ﹤0.01% 3502
2022
Q1
$206K Sell
10,264
-2,393
-19% -$49.7K ﹤0.01% 3667
2021
Q4
$321K Sell
12,657
-313
-2% -$8.08K ﹤0.01% 3367
2021
Q3
$350K Sell
12,970
-4,008
-24% -$115K ﹤0.01% 3202
2021
Q2
$491K Buy
16,978
+8,376
+97% +$232K ﹤0.01% 2995
2021
Q1
$226K Buy
+8,602
New +$244K ﹤0.01% 3283
2020
Q3
Sell
-10,050
Closed -$210K 3110
2020
Q2
$210K Buy
+10,050
New +$198K ﹤0.01% 2853

Other funds holding BMEZ

Envestnet Asset Management's BMEZ Position: Q1 2024 in Review

Envestnet Asset Management sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 21,066 shares — an estimated $309K sold.

Envestnet Asset Management first reported a position in BMEZ in Q2 2020 and held it in 8 quarters. The position peaked at $491K in Q2 2021. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Envestnet Asset Management reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 21,066 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $309K.
  • Envestnet Asset Management first reported a position in BlackRock Health Sciences Trust II in Q2 2020 and held it in 8 quarters.
  • Envestnet Asset Management's BlackRock Health Sciences Trust II position peaked at $491K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.